(MENAFN- GlobeNewsWire - Nasdaq) U.S. Molecular Imaging Market Projected to Hit USD 5.06 Billion and Europe USD 4.11 Billion by 2035, Supported by Advanced Imaging Technologies, Research Funding, and Expanding PET AdoptionAustin, June 04, 2026 (GLOBE NEWSWIRE) -- According to SNS Insider, The Molecular Imaging Market was valued at USD 9.25 Billion in 2025 and is expected to reach USD 14.23 Billion by 2035, growing at a CAGR of 4.5% from 2026–2035.
The global molecular imaging market is advancing steadily as molecular imaging provides non-invasive visualisation of biological processes at the cellular and molecular level, enabling early disease diagnosis, treatment planning, and therapy monitoring with precision that conventional anatomical imaging cannot achieve.
Market Size and Forecast
Market Size in 2026E: USD 9.67 Billion Market Size by 2035: USD 14.23 Billion CAGR: 4.5% from 2026 to 2035 Fastest Growing Region: Asia Pacific Largest Region: North America
Get a Sample Report of Molecular Imaging Market Forecast @
Segmentation Analysis:
By Modality
SPECT segment dominated the Molecular Imaging Market with approximately 42.00% share in 2025 due to the large installed base of SPECT and SPECT/CT systems in hospitals globally. PET-CT segment is the fastest growing with a CAGR of 5.80% during the forecast period due to its superior sensitivity and three-dimensional functional imaging capability.
By Application
Oncology segment dominated the Molecular Imaging Market with approximately 32.00% share in 2025 due to global cancer incidence exceeding 20 million new cases annually creating a structurally large and growing base of patients requiring molecular imaging at diagnosis. Neurology segment is the fastest growing with a CAGR of 5.40% during the forecast period as the Alzheimer's disease molecular imaging market has entered a new commercial phase.
By Product
Systems/Equipment segment dominated the Molecular Imaging Market with approximately 58.70% share in 2025 as capital equipment procurement for PET-CT scanners, SPECT systems, and cyclotron production infrastructure represents the highest-value individual procurement category. Radiopharmaceuticals segment is the fastest growing with a CAGR of 5.90% during the forecast period due to their consumption model creates recurring revenue that scales with procedure volume and expands with each new clinical indication approved.
By End User
Hospitals segment dominated the Molecular Imaging Market with approximately 54.20% share in 2025 as hospital-based nuclear medicine departments and PET imaging centres operate the majority of the world's molecular imaging systems. Research Institutes segment is the fastest growing with a CAGR of 5.30% during the forecast period as precision medicine programme investment, oncology clinical trial activity, and neurological disease research are creating above-average molecular imaging procurement in academic and commercial research settings.
For an In-Depth Strategic Briefing with Our Research Team, Connect Now @
Regional Insights:
North America led the global molecular imaging market in 2025. The United States made up about 76% of North America's revenues that year, thanks to strong NIH and NCI research funding, widespread use of top tech, and thorough Medicare coverage for PET oncology scans.
The U.S. Molecular Imaging Market was valued at approximately USD 3.37 Billion in 2025 and is expected to reach approximately USD 5.06 Billion by 2035, growing at a CAGR of approximately 4.15%. The U.S. leads the world in molecular imaging. In 2023, it made up about 76% of North America's revenue in this field. Their healthcare system's use of top-notch tech, the strong research support from the NIH and NCI, and big players like GE Healthcare and Siemens Healthineers being based there, really amp up both the tech level and commercial activity in this market.
The Europe Molecular Imaging Market is estimated to be USD 2.76 Billion in 2025 and is projected to reach USD 4.11 Billion by 2035, growing at a CAGR of 4.06% during 2026–2035. In Europe, advanced molecular imaging thrives due to tech wizardry from Siemens Healthineers, Philips, and IQVIA Biotech. The ecosystem is boosted by national health reimbursements and EU Horizon funds for research. Hence, it is a comprehensive setup for medical imaging innovations.
Asia Pacific leads in molecular imaging growth, thanks to developing health infrastructures in China, India, Japan, South Korea, and Australia. China dominates the region, grabbing about 44.8% of revenues. The region's growth is driven by the Healthy China 2030 plan, a rise in cancer cases, and more private hospitals adding such services.
Rising Cancer and Neurological Disease Prevalence to Boost Market Growth Globally
The rising number of cancer and neurological diseases drives growth in the molecular imaging market. With more than 20 million new cancer cases each year, and an aging population to boot, there's a constant need for imaging. Plus, Alzheimer's impacts over 55 million people worldwide. To top it off, FDA approved some new amyloid-lowering treatments in 2023. These therapies require a PET scan to confirm patients need them, creating a whole new commercial imaging demand.
Major Players Analysis Listed in the Molecular Imaging Market Report:
GE Healthcare Siemens Healthineers Philips Healthcare Canon Medical Systems Hitachi Medical Toshiba Medical Systems Bracco Diagnostics Lantheus Holdings Curium Positron Corporation Navidea Biopharmaceuticals Molecular Templates IBA Sofie Biosciences NovaBay Pharmaceuticals
Recent Developments:
2023: GE Healthcare launched a next-generation SPECT/CT system in late 2023, improving diagnostic efficiency in cardiology and oncology through enhanced image quality and reduced scan time that improves patient throughput in high-volume nuclear medicine departments. 2024: Lantheus Holdings expanded PYLARIFY commercial access in 2024 by achieving broader Medicare coverage across additional prostate cancer clinical indications, demonstrating the progressive reimbursement expansion pathway for novel diagnostic radiopharmaceuticals whose clinical evidence accumulation sustains coverage broadening.
Purchase Single User PDF of Molecular Imaging Market Report @
Exclusive Sections of the Report (The USPs):
DISEASE BURDEN & IMAGING DEMAND ANALYSIS – helps you understand how rising cancer, cardiovascular, and neurological disease prevalence is driving molecular imaging procedure volumes across regions. MOLECULAR IMAGING PROCEDURE VOLUME METRICS – helps you evaluate PET, SPECT, PET-CT, and PET-MRI utilization trends, supporting investment and capacity planning decisions. RADIOPHARMACEUTICAL UTILIZATION TRENDS – helps you identify demand patterns for FDG tracers, targeted radiotracers, and theranostic agents across clinical applications. HEALTHCARE INFRASTRUCTURE & INVESTMENT ANALYSIS – helps you assess regional spending on diagnostic imaging, PET/SPECT facility expansion, nuclear medicine centers, and government funding initiatives. AI & HYBRID IMAGING TECHNOLOGY ADOPTION METRICS – helps you track the integration of AI-powered image analysis, hybrid imaging systems, and advanced diagnostic technologies improving clinical outcomes. CLINICAL RESEARCH & REGULATORY APPROVAL LANDSCAPE – helps you understand ongoing clinical trial activity, novel imaging agent development, and regulatory approvals shaping future market opportunities.
Molecular Imaging Market Report Scope
| Report Attributes | Details |
| Market Size in 2025 | USD 9.25 Billion |
| Market Size by 2035 | USD 14.23 Billion |
| CAGR | CAGR of 4.5% From 2026 to 2035 |
| Base Year | 2025 |
| Forecast Period | 2026-2035 |
| Historical Data | 2022-2024 |
| Key Segments | . By Product Type (Manual Wound Irrigation Systems, Battery-Operated Wound Irrigation Systems)
. By Application (Surgical Wounds, Chronic Wounds, Traumatic Wounds, Burns, Others)
. By End User (Hospitals, Ambulatory Surgical Centers, Wound Care Centers, Home Care Settings, Others) |
| Regional Analysis/Coverage | North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America). |
Accelerated Molecular Imaging Market Demand: Find Comprehensive Insights and Trends in Our Full Report @
Other Trending Related Report:
The 3D Ultrasound Market was valued at USD 3.66 billion in 2023 and is projected to reach USD 7.79 billion by 2032, expanding at a CAGR of 8.77% during the forecast period from 2024 to 2032.
The Optical Imaging Market was valued at USD 1.99 billion in 2023 and is anticipated to grow to USD 5.30 billion by 2032, registering a CAGR of 11.52% between 2024 and 2032.
The Photoacoustic Imaging Market was estimated at USD 94.51 million in 2025 and is forecast to reach USD 161.96 million by 2035, growing at a CAGR of 5.4% over the period from 2026 to 2035.
The Multimodal Imaging Market was valued at USD 4.43 billion in 2023 and is expected to attain USD 7.43 billion by 2032, progressing at a CAGR of 5.93% during the 2024–2032 forecast period.
The Clinical Trial Imaging Market was valued at USD 1.34 billion in 2024 and is projected to reach USD 2.45 billion by 2032, growing at a CAGR of 7.86% throughout the forecast period from 2025 to 2032.
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
CONTACT: Contact Data
Contact Us:
Rohan Jadhav - Principal Consultant
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
![]()
MENAFN04062026004107003653ID1111210741
Comments
No comment